Agenda features discussion of life sciences industry trends, business value of model-informed drug development strategies, and impact of generative AI on biosimulation and regulatory sciences RADNOR, PA– April. 18, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will host the first-ever Certainty Conference. At this event, … Continued
PRINCETON, NJ – April 16, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying platform that integrates its many scientific software solutions. Customers log into Certara Cloud using a single ID to access and manage their licensed software, linking predictive solutions to … Continued
New, spacious location in Radnor, Pennsylvania will support the needs of company’s growing workforce and business, strengthen presence in the state RADNOR, PA – April 15, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the relocation of its corporate headquarters to Radnor, Pennsylvania. The new headquarters is 13 … Continued
Learn about biosimilars, their benefits for patients who take biologic drugs, and how pharmaceutical companies demonstrate their bioequivalence to approved biosimilars.
This blog reviews the role of the endogenous biomarker, CP-1, for assessing OATP1B transporter-mediated drug-drug interactions and their clinical implications.
Gain an understanding of CDISC SEND dataset creation challenges impacting the biopharma industry, and how these factors could delay regulatory submissions and strategic initiatives.
Join us for an in-person event where you can learn from drug development experts, network with peers, and discover the latest trends and best practices in biosimulation.
Authors: Peter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan, Suruchi Bakshi, Florence Véronneau-Veilleux, Matthew Moye, Kazutaka Sekiguchi, Guy Meno-Tetang, Aparna Mohan, R. Maithreye, Veena A. Thomas, Frank Gibbons, Antonio Cabal, Jean-Marie Bouteiller, Hugo Geerts Age-related central neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease, are a rising public health concern and have been plagued by repeated drug … Continued
Learn how drug discovery tools can help pharmaceutical industry professionals make more informed decisions based on robust data analytics
